The impact of COVID‐19 vaccine on sperm quality
Objective To examine the effect of the BNT162b, mRNA, SARS‐CoV‐2 virus vaccine on sperm quality. Methods This was a prospective cohort study conducted on sperm donors at the sperm bank of a tertiary, university affiliated medical center. All sperm donors donated sperm repeatedly and the average sper...
Gespeichert in:
| Veröffentlicht in: | International journal of gynecology and obstetrics 2022-07, Vol.158 (1), p.116-120 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 120 |
|---|---|
| container_issue | 1 |
| container_start_page | 116 |
| container_title | International journal of gynecology and obstetrics |
| container_volume | 158 |
| creator | Barda, Shimi Laskov, Ido Grisaru, Dan Lehavi, Ofer Kleiman, Sandra Wenkert, Atalia Azem, Foad Hauser, Ron Michaan, Nadav |
| description | Objective
To examine the effect of the BNT162b, mRNA, SARS‐CoV‐2 virus vaccine on sperm quality.
Methods
This was a prospective cohort study conducted on sperm donors at the sperm bank of a tertiary, university affiliated medical center. All sperm donors donated sperm repeatedly and the average sperm parameters of all available samples were compared before and after receiving the SARS‐CoV‐2 vaccine. Each donor served as his own control. For all participants, at‐least one sperm sample was received 72 days after completing the second vaccine. Main outcome measures included total sperm count, total motile count and percent of motile sperm.
Results
A total of 898 sperm samples from 33 sperm donors that were vaccinated with the Pfizer BNT162b, mRNA, SARS‐CoV‐2 virus vaccine were analyzed, 425 samples were received before the vaccine, while 473 samples were received after vaccination. Total sperm count and total motile count increased after the second vaccine compared to samples before vaccination. Percent of motile sperm did not change after vaccine.
Conclusion
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality. Patients and physicians should be counseled accordingly.
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality. |
| doi_str_mv | 10.1002/ijgo.14135 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9087610</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2626223448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4615-fbc472dbda4bb523017dc694a47e869838559aab384285d521c250ebf6f1719d3</originalsourceid><addsrcrecordid>eNp9kMtKw0AUhgdRbK1ufADJUoTUuSYzG0Gq1kqhm-p2mEwm7ZTczCSV7nwEn9EnMTW16EbO4izOx_cffgDOERwiCPG1XS2KIaKIsAPQRzwUPqGhOAT99gj9EAvcAyfOrSCEKEToGPQIQ5gHAekDNF8az2al0rVXJN5o9jK5-3z_QMJbK61tbrwi91xpqsx7bVRq680pOEpU6szZbg_A88P9fPToT2fjyeh26msaIOYnkaYhjqNY0ShimLTRsQ4EVTQ0PBCccMaEUhHhFHMWM4w0ZtBESZC0T4qYDMBN5y2bKDOxNnldqVSWlc1UtZGFsvLvJbdLuSjWUkAeBgi2gsudoCpeG-NqmVmnTZqq3BSNkzhoBxNKeYtedaiuCucqk-xjEJTbjuW2Y_ndcQtf_H5sj_6U2gKoA95sajb_qOTkaTzrpF9DvIZn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626223448</pqid></control><display><type>article</type><title>The impact of COVID‐19 vaccine on sperm quality</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Barda, Shimi ; Laskov, Ido ; Grisaru, Dan ; Lehavi, Ofer ; Kleiman, Sandra ; Wenkert, Atalia ; Azem, Foad ; Hauser, Ron ; Michaan, Nadav</creator><creatorcontrib>Barda, Shimi ; Laskov, Ido ; Grisaru, Dan ; Lehavi, Ofer ; Kleiman, Sandra ; Wenkert, Atalia ; Azem, Foad ; Hauser, Ron ; Michaan, Nadav</creatorcontrib><description>Objective
To examine the effect of the BNT162b, mRNA, SARS‐CoV‐2 virus vaccine on sperm quality.
Methods
This was a prospective cohort study conducted on sperm donors at the sperm bank of a tertiary, university affiliated medical center. All sperm donors donated sperm repeatedly and the average sperm parameters of all available samples were compared before and after receiving the SARS‐CoV‐2 vaccine. Each donor served as his own control. For all participants, at‐least one sperm sample was received 72 days after completing the second vaccine. Main outcome measures included total sperm count, total motile count and percent of motile sperm.
Results
A total of 898 sperm samples from 33 sperm donors that were vaccinated with the Pfizer BNT162b, mRNA, SARS‐CoV‐2 virus vaccine were analyzed, 425 samples were received before the vaccine, while 473 samples were received after vaccination. Total sperm count and total motile count increased after the second vaccine compared to samples before vaccination. Percent of motile sperm did not change after vaccine.
Conclusion
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality. Patients and physicians should be counseled accordingly.
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality.</description><identifier>ISSN: 0020-7292</identifier><identifier>EISSN: 1879-3479</identifier><identifier>DOI: 10.1002/ijgo.14135</identifier><identifier>PMID: 35128663</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Clinical ; COVID‐19 ; sperm count ; sperm quality vaccine</subject><ispartof>International journal of gynecology and obstetrics, 2022-07, Vol.158 (1), p.116-120</ispartof><rights>2022 International Federation of Gynecology and Obstetrics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4615-fbc472dbda4bb523017dc694a47e869838559aab384285d521c250ebf6f1719d3</citedby><cites>FETCH-LOGICAL-c4615-fbc472dbda4bb523017dc694a47e869838559aab384285d521c250ebf6f1719d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijgo.14135$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijgo.14135$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35128663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barda, Shimi</creatorcontrib><creatorcontrib>Laskov, Ido</creatorcontrib><creatorcontrib>Grisaru, Dan</creatorcontrib><creatorcontrib>Lehavi, Ofer</creatorcontrib><creatorcontrib>Kleiman, Sandra</creatorcontrib><creatorcontrib>Wenkert, Atalia</creatorcontrib><creatorcontrib>Azem, Foad</creatorcontrib><creatorcontrib>Hauser, Ron</creatorcontrib><creatorcontrib>Michaan, Nadav</creatorcontrib><title>The impact of COVID‐19 vaccine on sperm quality</title><title>International journal of gynecology and obstetrics</title><addtitle>Int J Gynaecol Obstet</addtitle><description>Objective
To examine the effect of the BNT162b, mRNA, SARS‐CoV‐2 virus vaccine on sperm quality.
Methods
This was a prospective cohort study conducted on sperm donors at the sperm bank of a tertiary, university affiliated medical center. All sperm donors donated sperm repeatedly and the average sperm parameters of all available samples were compared before and after receiving the SARS‐CoV‐2 vaccine. Each donor served as his own control. For all participants, at‐least one sperm sample was received 72 days after completing the second vaccine. Main outcome measures included total sperm count, total motile count and percent of motile sperm.
Results
A total of 898 sperm samples from 33 sperm donors that were vaccinated with the Pfizer BNT162b, mRNA, SARS‐CoV‐2 virus vaccine were analyzed, 425 samples were received before the vaccine, while 473 samples were received after vaccination. Total sperm count and total motile count increased after the second vaccine compared to samples before vaccination. Percent of motile sperm did not change after vaccine.
Conclusion
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality. Patients and physicians should be counseled accordingly.
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality.</description><subject>Clinical</subject><subject>COVID‐19</subject><subject>sperm count</subject><subject>sperm quality vaccine</subject><issn>0020-7292</issn><issn>1879-3479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKw0AUhgdRbK1ufADJUoTUuSYzG0Gq1kqhm-p2mEwm7ZTczCSV7nwEn9EnMTW16EbO4izOx_cffgDOERwiCPG1XS2KIaKIsAPQRzwUPqGhOAT99gj9EAvcAyfOrSCEKEToGPQIQ5gHAekDNF8az2al0rVXJN5o9jK5-3z_QMJbK61tbrwi91xpqsx7bVRq680pOEpU6szZbg_A88P9fPToT2fjyeh26msaIOYnkaYhjqNY0ShimLTRsQ4EVTQ0PBCccMaEUhHhFHMWM4w0ZtBESZC0T4qYDMBN5y2bKDOxNnldqVSWlc1UtZGFsvLvJbdLuSjWUkAeBgi2gsudoCpeG-NqmVmnTZqq3BSNkzhoBxNKeYtedaiuCucqk-xjEJTbjuW2Y_ndcQtf_H5sj_6U2gKoA95sajb_qOTkaTzrpF9DvIZn</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Barda, Shimi</creator><creator>Laskov, Ido</creator><creator>Grisaru, Dan</creator><creator>Lehavi, Ofer</creator><creator>Kleiman, Sandra</creator><creator>Wenkert, Atalia</creator><creator>Azem, Foad</creator><creator>Hauser, Ron</creator><creator>Michaan, Nadav</creator><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202207</creationdate><title>The impact of COVID‐19 vaccine on sperm quality</title><author>Barda, Shimi ; Laskov, Ido ; Grisaru, Dan ; Lehavi, Ofer ; Kleiman, Sandra ; Wenkert, Atalia ; Azem, Foad ; Hauser, Ron ; Michaan, Nadav</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4615-fbc472dbda4bb523017dc694a47e869838559aab384285d521c250ebf6f1719d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical</topic><topic>COVID‐19</topic><topic>sperm count</topic><topic>sperm quality vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barda, Shimi</creatorcontrib><creatorcontrib>Laskov, Ido</creatorcontrib><creatorcontrib>Grisaru, Dan</creatorcontrib><creatorcontrib>Lehavi, Ofer</creatorcontrib><creatorcontrib>Kleiman, Sandra</creatorcontrib><creatorcontrib>Wenkert, Atalia</creatorcontrib><creatorcontrib>Azem, Foad</creatorcontrib><creatorcontrib>Hauser, Ron</creatorcontrib><creatorcontrib>Michaan, Nadav</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barda, Shimi</au><au>Laskov, Ido</au><au>Grisaru, Dan</au><au>Lehavi, Ofer</au><au>Kleiman, Sandra</au><au>Wenkert, Atalia</au><au>Azem, Foad</au><au>Hauser, Ron</au><au>Michaan, Nadav</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of COVID‐19 vaccine on sperm quality</atitle><jtitle>International journal of gynecology and obstetrics</jtitle><addtitle>Int J Gynaecol Obstet</addtitle><date>2022-07</date><risdate>2022</risdate><volume>158</volume><issue>1</issue><spage>116</spage><epage>120</epage><pages>116-120</pages><issn>0020-7292</issn><eissn>1879-3479</eissn><abstract>Objective
To examine the effect of the BNT162b, mRNA, SARS‐CoV‐2 virus vaccine on sperm quality.
Methods
This was a prospective cohort study conducted on sperm donors at the sperm bank of a tertiary, university affiliated medical center. All sperm donors donated sperm repeatedly and the average sperm parameters of all available samples were compared before and after receiving the SARS‐CoV‐2 vaccine. Each donor served as his own control. For all participants, at‐least one sperm sample was received 72 days after completing the second vaccine. Main outcome measures included total sperm count, total motile count and percent of motile sperm.
Results
A total of 898 sperm samples from 33 sperm donors that were vaccinated with the Pfizer BNT162b, mRNA, SARS‐CoV‐2 virus vaccine were analyzed, 425 samples were received before the vaccine, while 473 samples were received after vaccination. Total sperm count and total motile count increased after the second vaccine compared to samples before vaccination. Percent of motile sperm did not change after vaccine.
Conclusion
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality. Patients and physicians should be counseled accordingly.
The Pfizer BNT162b, SARS‐CoV‐2 vaccine has no deleterious effect on sperm quality.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>35128663</pmid><doi>10.1002/ijgo.14135</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7292 |
| ispartof | International journal of gynecology and obstetrics, 2022-07, Vol.158 (1), p.116-120 |
| issn | 0020-7292 1879-3479 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9087610 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Clinical COVID‐19 sperm count sperm quality vaccine |
| title | The impact of COVID‐19 vaccine on sperm quality |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A46%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20COVID%E2%80%9019%20vaccine%20on%20sperm%20quality&rft.jtitle=International%20journal%20of%20gynecology%20and%20obstetrics&rft.au=Barda,%20Shimi&rft.date=2022-07&rft.volume=158&rft.issue=1&rft.spage=116&rft.epage=120&rft.pages=116-120&rft.issn=0020-7292&rft.eissn=1879-3479&rft_id=info:doi/10.1002/ijgo.14135&rft_dat=%3Cproquest_pubme%3E2626223448%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2626223448&rft_id=info:pmid/35128663&rfr_iscdi=true |